NCT06279429

Sucrosomial Iron on Insomnia in Non-dialysis Chronic Kidney Disease Patients With Iron Deficiency Anemia

• Status: Unknown
• Phase: N/A
• Study type: Interventional
• Enrollment: 100 (estimated)
• Sponsor: Kuang Tien General Hospital · Academic / Other
• Sex: All
• Age: 20 Years – 80 Years
• Healthy volunteers: Not accepted

Summary

Insomnia or sleep disturbance is a common disorder in patients with chronic kidney disease (CKD), but is often unrecognized and undertreated. It is known that sleep disorders may indirectly cause a variety of diseases and affect quality of life. The most common sleep disorders that occur in CKD are insomnia, excessive daytime sleepiness, obstructive or central sleep apnea (SA), and sleep disorders. This study evaluates the effectiveness and safety of Sideral® Sucrosomial Iron and iron chewable tablets 100mg commonly used in health insurance on sleep disorders in patients with CKD and iron deficiency anemia.

Conditions

• CKD
• Sleep Disorder

Interventions

Type	Name	Description
DIETARY_SUPPLEMENT	Sideral® Sucrosomial Iron	Sucrosomial Iron 30mg
DIETARY_SUPPLEMENT	Iron chewable tablet	Iron chewable tablet 100mg

Timeline

• Start date: 2022-05-31
• Primary completion: 2024-12-31
• Completion: 2024-12-31
• First posted: 2024-02-28
• Last updated: 2024-02-29

Locations

1 site across 1 country: Taiwan